Role of leptin in reverse epidemiology in chronic kidney disease

Seminars in Dialysis

Volumn 20, Issue 6, 2007, Pages 534-538

  Scholze, Alexandra ^a   Tepel, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LEPTIN;

BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; HOMEOSTASIS; HUMAN; OBESITY; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC FACTORS; HOMEOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; LEPTIN; OBESITY; RISK FACTORS;

EID: 35948931066     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2007.00334.x     Document Type: Review

References (61)

1. Auwerx J, Bart S : Leptin. Lancet 351 : 737 742, 1998
2. Jequier E, Tappy L : Regulation of body weight in humans. Physiol Rev 79 : 451 480, 1999
3. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM : Leptin enters the brain by a saturable system independent of insulin. Peptides 17 : 305 311, 1996
4. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV : Decreased cerebrospinal-fluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348 : 159 161, 1996
5. Munzberg H, Flier JS, Bjorbaek C : Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology 145 : 4880 4889, 2004
6. Considine RV : Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions. Semin Vasc Med 5 : 15 24, 2005
7. Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL : Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304 : 110 115, 2004
8. Eikelis N, Lambert G, Wiesner G, Kaye D, Schlaich M, Morris M, Hastings J, Socratous F, Esler M : Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab 286 : E744 E752, 2004
9. Evans BA, Agar L, Summers RJ : The role of the sympathetic nervous system in the regulation of leptin synthesis in C57BL/6 mice. FEBS Lett 444 : 149 154, 1999
10. Matsumura K, Abe I, Tsuchihashi T, Fujishima M : Central effects of leptin on cardiovascular and neurohormonal responses in conscious rabbits. Am J Physiol Regul Integr Comp Physiol 278 : R1314 R1320, 2000
11. Tilg H, Moschen AR : Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6 : 772 783, 2006
12. Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN : Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 59 : 1315 1323, 2001
13. Cock TA, Auwerx J : Leptin: cutting the fat off the bone. Lancet 362 : 1572 1574, 2003
14. Ren J : Leptin and hyperleptinemia - from friend to foe for cardiovascular function. J Endocrinol 181 : 1 10, 2004
15. Nakagawa K, Higashi Y, Sasaki S, Oshima T, Matsuura H, Chayama K : Leptin causes vasodilation in humans. Hypertens Res 25 : 161 165, 2002
16. Cherradi N, Capponi AM, Gaillard RC, Pralong FP : Decreased expression of steroidogenic acute regulatory protein: a novel mechanism participating in the leptin-induced inhibition of glucocorticoid biosynthesis. Endocrinology 142 : 3302 33088, 2001
17. Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK : Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab 82 : 1635 1637, 1997
18. Carlsson B, Ankarberg C, Rosberg S, Norjavaara E, Albertsson-Wikland K, Carlsson LM : Serum leptin concentrations in relation to pubertal development. Arch Dis Child 77 : 396 400, 1997
19. Carlson MG, Snead WL, Oeser AM, Butler MG : Plasma leptin concentrations in lean and obese human subjects and Prader-Willi syndrome: comparison of RIA and ELISA methods. J Lab Clin Med 133 : 75 80, 1999
20. Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, el-Tawil K, Rude RK, Kamdar V : Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 82 : 579 84, 1997
21. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF : Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334 : 292 295, 1996
22. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S : Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1 : 1155 1161, 1995
23. Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP : Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 142 : 403 411, 2005
24. Zelissen PM, Stenlof K, Lean ME, Fogteloo J, Keulen ET, Wilding J, Finer N, Rossner S, Lawrence E, Fletcher C, McCamish M Author Group : Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial. Diabetes Obes Metab 7 : 755 761, 2005
25. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A : Leptin-replacement therapy for lipodystrophy. N Engl J Med 346 : 570 578, 2002
26. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BR, Kurnik PB, O'Connor J, Sinha M, Caro JF : Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51 : 1980 1985, 1997
27. Nordfors L, Lonnqvist F, Heimburger O, Danielsson A, Schalling M, Stenvinkel P : Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 54 : 1267 1275, 1998
28. Heimburger O, Lonnqvist F, Danielsson A, Nordenstrom J, Stenvinkel P : Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8 : 1423 1430, 1997
29. Diez JJ, Iglesias P, Fernandez-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R : Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 62 : 242 249, 2005
30. Fontan MP, Rodriguez-Carmona A, Cordido F, Garcia-Buela J : Hyperleptinemia in uremic patients undergoing conservative management, peritoneal dialysis, and hemodialysis: a comparative analysis. Am J Kidney Dis 34 : 824 831, 1999
31. Johansen KL, Mulligan K, Tai V, Schambelan M : Leptin, body composition, and indices of malnutrition in patients on dialysis. J Am Soc Nephrol 9 : 1080 1084, 1998
32. Malyszko J, Malyszko J, Wolczynski S, Mysliwiec M : Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related. Nephrol Dial Transplant 21 : 145 152, 2006
33. El Haggan W, Chauveau P, Barthe N, Merville P, Potaux L, Aparicio M : Serum leptin, body fat, and nutritional markers during the six months post-kidney transplantation. Metabolism 53 : 614 619, 2004
34. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH : Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 115 : 1659 1665, 2005
35. Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O : Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 11 : 1303 1309, 2000
36. Bossola M, Muscaritoli M, Valenza V, Panocchia N, Tazza L, Cascino A, Laviano A, Liberatori M, Lodovica Moussier M, Rossi Fanelli F, Luciani G : Anorexia and serum leptin levels in hemodialysis patients. Nephron Clin Pract 97 : 76 82, 2004
37. Hung SC, Tung TY, Yang CS, Tarng DC : High-calorie supplementation increases serum leptin levels and improves response to rHuEPO in long-term hemodialysis patients. Am J Kidney Dis 45 : 1073 1083, 2005
38. Rammohan M, Kalantar-Zadeh K, Liang A, Ghossein C : Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr 15 : 345 355, 2005
39. Reilly MP, Iqbal N, Schutta M, Wolfe ML, Scally M, Localio AR, Rader DJ, Kimmel SE : Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 89 : 3872 3878, 2004
40. Scholze A, Rattensperger D, Zidek W, Tepel M : Low serum leptin concentration predicts mortality in patients with chronic kidney disease stage 5 on hemodialysis therapy. Obesity 15 : 1617 1622, 2007
41. Aguilera A, Bajo MA, Rebollo F, Diez JJ, Diaz C, Paiva A, Codoceo R, Selgas R : Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients. Adv Perit Dial 18 : 212 217, 2002
42. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA : Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13 : 1061 1066, 2002
43. Estrada V, Serrano-Rios M, Martinez Larrad MT, Villar NG, Gonzalez Lopez A, Tellez MJ, Fernandez C : Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy. J Acquir Immune Defic Syndr 29 : 32 40, 2002
44. Grinspoon S, Carr A : Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352 : 48 62, 2005
45. Hegele RA, Kraw ME, Ban MR, Miskie BA, Huff MW, Cao H : Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arterioscler Thromb Vasc Biol 23 : 111 116, 2003
46. Hegele RA : Premature atherosclerosis associated with monogenic insulin resistance. Circulation 103 : 2225 2229, 2001
47. Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, McMurray JJ : Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart 82 : 352 356, 1999
48. Filippatos GS, Tsilias K, Venetsanou K, Karambinos E, Manolatos D, Kranidis A, Antonellis J, Kardaras F, Anthopoulos L, Baltopoulos G : Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system. Int J Cardiol 76 : 117 122, 2000
49. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP : Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 83 : 280 283, 1998
50. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA : Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 59 : 1114 1120, 2001
51. Teta D, Bevington A, Brown J, Pawluczyk I, Harris K, Walls J : Acidosis downregulates leptin production from cultured adipocytes through a glucose transport-dependent post-transcriptional mechanism. J Am Soc Nephrol 14 : 2248 2254, 2003
52. Kopple JD, Kalantar-Zadeh K, Mehrotra R : Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int Suppl 95 : S21 S27, 2005
53. Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V : Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 199 : 15 24, 2000
54. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI : Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394 : 897 901, 1998
55. Beltowski J, Wojcicka G, Borkowska E : Human leptin stimulates systemic nitric oxide production in the rat. Obes Res 10 : 939 946, 2002
56. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, Grunfeld C : Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276 : R136 R142, 1999
57. Nasri H : Serum leptin concentration and left ventricular hypertrophy and function in maintenance hemodialysis patients. Minerva Urol Nefrol 58 : 189 193, 2006
58. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD : Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 : 793 808, 2003
59. Kalantar-Zadeh K, Kopple JD : Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 151 : 57 69, 2006
60. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB : Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 : 543 554, 2005
61. Kalantar-Zadeh K, Abbott KC, Kronenberg F, Anker SD, Horwich TB, Fonarow GC : Epidemiology of dialysis patients and heart failure patients. Semin Nephrol 26 : 118 133, 2006